Fingerprint
Dive into the research topics of 'Phase i ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma
A. Patnaik, G. J. Weiss, K. P. Papadopoulos, C. C. Hofmeister, R. Tibes, A. Tolcher, R. Isaacs, J. Jac, M. Han, F. C. Payumo, M. M. Cotreau, R. K. Ramanathan
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations